ATM polymorphism IVS62+60G>A is not associated with disease aggressiveness in prostate cancer

Urology

Volumn 67, Issue 6, 2006, Pages 1320-1323

  Lee Browning IV, Robert E ^a   Li, Hecheng ^a   Shinohara, Eric T ^a   Cai, Qiuyin ^a   Chen, Heidi ^a   Courtney, Regina ^a   Cao, Carolyn ^a   Zheng, Wei ^a   Lu, Bo ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ATM GENE; BREAST CANCER; CANCER DIAGNOSIS; CANCER GRADING; CANCER RELAPSE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; FISHER EXACT TEST; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; STATISTICAL SIGNIFICANCE;

AGED; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; SEVERITY OF ILLNESS INDEX; TUMOR SUPPRESSOR PROTEINS;

EID: 33744522009     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2005.12.012     Document Type: Article

References (16)

1. Parkin D.M., Laara E., and Muir C.S. Estimates of the worldwide frequency of sixteen cancers in 1980. Int J Cancer 41 (1988) 184-197
2. Parkin D.M., Pisani P., and Ferlay J. Estimates of the world-wide incidence of 25 major cancers in 1990. Int J Cancer 80 (1999) 870-873
3. Parkin D.M., Bray F.I., and Devesa S.S. Cancer burden in the year 2000. the global picture. Eur J Cancer 37 suppl (2000) S4-S66
4. Quinn M., and Babb P. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I. international comparisons. BJU Int 90 (2002) 162-173
5. Siegal J.A., Yu E., and Brawer M.K. Topography of neovascularity in human prostate carcinoma. Cancer 75 (1995) 2545-2551
6. Savitsky K., Bar-Shira A., Gilad S., et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268 (1995) 1749-1753
7. Gatti R.A., Berkel I., Boder E., et al. Localization of ataxia-telangiectasia gene to chromosome 11q22-23. Nature 336 (1988) 577-580
8. Uziel T., Savitsky K., Platzer M., et al. Genomic organization of the ATM gene. Genomics 33 (1996) 317-320
9. Platzer M., Rotman G., Bauer D., et al. Ataxia telangiectasia locus. sequence analysis of 184 kb of human genomic DNA containing the entire ATM gene. Genome Res 7 (1997) 592-605
10. Kastan M.B., and Lim D.S. The many substrates and functions of ATM. Nat Rev Mol Cell Biol 1 (2000) 179-186
11. Borresen A.L., Anderson T.I., Treti S., et al. Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia. Genes Chromosom Cancer 2 (1990) 339-340
12. Swift M., Morrell D., Massey R.B., et al. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 325 (1991) 1831-1836
13. Maillet P., Chappuis P.O., Vaudan G., et al. A polymorphism in the ATM gene modulates the penetrance of hereditary non-polyposis colorectal cancer. Int J Cancer 88 (2000) 928-931
14. American Joint Committee on Cancer. Prostate, in AJCC Cancer Staging Manual. 6th ed. (2002), Springer, New York 309-316
15. Angèle S., Falconer A., Edwards S.M., et al. ATM polymorphisms as risk factors for prostate cancer development. Br J Cancer 91 (2004) 783-787
16. Thorstenson Y., Shen P., Tusher V., et al. Global analysis of ATM polymorphism reveals significant functional constraint. Am J Hum Genet 69 (2001) 396-412